NDA 022496 · Pacira Pharms INC
Exparel
Bupivacaine · Injection · Amide Local Anesthetic
Last checked: Nov 20, 2026Latest source record: Nov 28, 2023 (newest FDA action)Source: Drugs@FDA, openFDA, CMS, ClinicalTrials.gov, PubMedMethods & limitations
First approved
2011
Oct 28, 2011
Approved uses
4
Original approval plus efficacy supplements
Registered trials
2,836
341 Phase 3, 228 recruiting
FAERS reports
9,403
7,042 serious, 592 with death reported
AI brief across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, FAERS and PubMed data on this page, plus web searches for pricing, exclusivity and pending FDA decisions.
What it is approved for
From the label in effect Nov 9, 2026.
EXPAREL is indicated to produce postsurgical: Local analgesia via infiltration in patients aged 6 years and older Regional analgesia via an interscalene brachial plexus nerve block in adults Regional analgesia via a sciatic nerve block in the popliteal fossa in adults Regional analgesia via an adductor canal block in adults EXPAREL contains bupivacaine, an amide local anesthetic, and is indicated to produce postsurgical: Local analgesia via infiltration in patients aged 6 years and older ( 1 ). Regional analgesia via an interscalene brachial plexus nerve block in adults ( 1 ). Regional analgesia via a sciatic nerve block in the popliteal fossa in adults ( 1 ). Regional analgesia via an adductor canal block in adults ( 1 ). Limitations of Use The safety and effectiveness of EXPAREL have not been established to produce postsurgical regional analgesia via other nerve blocks besides an interscalene brachial plexus nerve block, a sciatic nerve block in the popliteal fossa, or an adductor canal block. Limitations of Use The safety and effectiveness of EXPAREL have not been established to produce postsurgical regional analgesia via other nerve blocks besides an interscalene brachial plexus nerve block, a sciatic nerve block in the popliteal fossa, or an adductor canal block.
Mechanism: Local anesthetics block the generation and the conduction of nerve impulses presumably by increasing the threshold for electrical excitation in the nerve, by slowing the propagation of the nerve impulse, and by reducing the rate of rise of the action potential. In general, the progression of anesthesia is related to the diameter, myelination, and conduction velocity of affected nerve fibers. Clinically, the order of loss of nerve function is as follows: (1) pain, (2) temperature, (3) touch, (4) proprioception, and (5) skeletal muscle tone.
Therapeutic areas: Pain and anesthesia
Approval history
Original approval and efficacy supplements (new uses, populations or doses), newest first, with FDA's letters and labels.
- Nov 9, 2023 Supplement 44 · Efficacy LabelLetter
- Mar 22, 2021 Supplement 35 · Efficacy LabelLetter
- Apr 6, 2018 Supplement 9 · Efficacy Label
- Oct 28, 2011 Original approval · Type 3 - New Dosage Form LabelLetterReview
2 products under this application
- EXPAREL · BUPIVACAINE 266MG/20ML (13.3MG/ML) · INJECTABLE, LIPOSOMAL, INJECTION · Prescription · TE AP
- EXPAREL · BUPIVACAINE 133MG/10ML (13.3MG/ML) · INJECTABLE, LIPOSOMAL, INJECTION · Prescription · TE AP
Clinical trials
Interventional ClinicalTrials.gov studies with "Bupivacaine" as an intervention, any sponsor and status, largest first.
Vanderbilt University Medical CenterAcademic, hospital or other
NCT02726620 · 22,435 participants · Start Jan 5, 2017 · Primary completion Dec 31, 2017
Drug: Propofol; Sevoflurane and 32 more · For: Hypotension
Sites: Nashville, Tennessee
- Perioperative Multimodal Analgesia Protocol for Supratentorial CraniotomyPivotal-lookingNot yet recruiting
Beijing Tiantan HospitalAcademic, hospital or other
NCT06406829 · 2,000 participants (planned) · Start Feb 9, 2026 · Primary completion Dec 31, 2026
Drug: Dexmedetomidine; Normal saline · For: Postoperative Pain; Analgesia; Supratentorial Brain Tumor
- Perioperative Multimodal Analgesia for Supratentorial CraniotomyPivotal-lookingRecruiting
Beijing Tiantan HospitalAcademic, hospital or other
NCT07441421 · 2,000 participants (planned) · Start Mar 9, 2026 · Primary completion Dec 31, 2027
Drug: Dexmedetomidine · For: Postoperative Pain; Analgesia; Supratentorial Brain Tumor
Sites: Beijing, China
- A Sequenced Strategy for Improving Outcomes in People With Knee Osteoarthritis PainPivotal-lookingCompleted
Johns Hopkins UniversityAcademic, hospital or other
NCT04504812 · 1,937 participants · Start Feb 1, 2021 · Primary completion Apr 8, 2025
Drug: Duloxetine · For: Knee Osteoarthritis
Sites: Sacramento, California; San Diego, California; Aurora, Colorado · 24 sites in all
- Anesthesia and Perioperative Neurocognitive Disorders in the Elderly Patients Undergoing Hip Fracture Surgery Platform Trial (ANDES Platform Trial)Pivotal-lookingRecruiting
Second Affiliated Hospital of Wenzhou Medical UniversityAcademic, hospital or other
NCT06452147 · 1,860 participants (planned) · Start Jun 19, 2024 · Primary completion Jul 30, 2028
Drug: Bupivacaine liposome; Regular local anesthetic and 1 more · For: Anesthesia; Hip Fractures; Dementia and 2 more
Sites: Dongyang, China; Hangzhou, China; Jinhua, China · 13 sites in all
- Catheter Outcomes With Sternotomy Cardiac OperatedPivotal-lookingCompleted
Assistance Publique - Hôpitaux de ParisAcademic, hospital or other
NCT01648777 · 1,502 participants · Start Mar 2012 · Primary completion Jan 2015
Drug: placebo · For: Pneumonia; Cardiac Surgery; Multiperforated Catheter and 2 more
Sites: Paris, France
- Efficacy and Safety of Intrathecal Morphine for Postoperative Pain Management Following Planned Caesarean SectionPivotal-lookingRecruiting
Anne Juul WikkelsøAcademic, hospital or other
NCT06797973 · 1,312 participants (planned) · Start Jul 15, 2025 · Primary completion May 31, 2027
Drug: Intrathecal Morphine; Placebo (Sodium Chloride Injection, 0.9%) · For: Caesarean Section; Postoperative Pain
Sites: Aarhus, Denmark; Copenhagen, Denmark; Herlev, Denmark · 9 sites in all
- Combined Spinal-epidural Anesthesia for Cesarean Section Without Prophylactical Prehydration and VasopressorsPivotal-lookingStatus unknown
Shenzhen People's HospitalAcademic, hospital or other
NCT03497364 · 930 participants (planned) · Start May 1, 2018 · Primary completion Nov 30, 2021
Drug: bupivacaine; ropivacaine · For: Cesarean Section; Anesthesia, Spinal
Sites: Shenzhen, China
Most reported adverse reactions
FAERS reports naming this application or brand. Unverified reports, not rates; a report can name several drugs.
- off label use905
- pain772
- drug ineffective736
- hypotension548
- nausea414
- hypoaesthesia381
- maternal exposure during pregnancy379
- exposure during pregnancy336
- drug withdrawal syndrome281
- vomiting275
- maternal exposure during delivery258
- labelled drug-drug interaction medication error250
FAERS reports by year
By the date FDA received the report.
View as table
| Year | Reports |
|---|---|
| 2004 | 182 |
| 2005 | 132 |
| 2006 | 187 |
| 2007 | 152 |
| 2008 | 206 |
| 2009 | 224 |
| 2010 | 6 |
| 2011 | 11 |
| 2012 | 135 |
| 2013 | 394 |
| 2014 | 398 |
| 2015 | 294 |
| 2016 | 614 |
| 2017 | 657 |
| 2018 | 646 |
| 2019 | 772 |
| 2020 | 912 |
| 2021 | 631 |
| 2022 | 683 |
| 2023 | 675 |
| 2024 | 543 |
| 2025 | 648 |
| 2026 | 301 |
Recalls
1 FDA enforcement reports for this application.
Nov 21, 2019 · Class II · Terminated
Sub Potent Drug: Out of Specification (OOS)
Shortages
FDA's drug shortage list.
Not on FDA's shortage list.
Medicare spending
CMS Spending by Drug. Part D is pharmacy-dispensed; Part B is given in a clinic or hospital outpatient setting. Spending is before manufacturer rebates.
Not found under this brand name in Medicare's Part D or Part B Spending by Drug data. CMS lists some drugs under the generic name only.
Published evidence
PubMed clinical trials, meta-analyses and systematic reviews, most relevant first.
- Analgesic Effectiveness of Liposomal Bupivacaine versus Plain Local Anesthetics for Abdominal Fascial Plane Blocks: A Systematic Review and Meta-analysis of Randomized Trials.
Hussain N, Speer J, Abdallah FW · Anesthesiology 2024 · Meta-Analysis, Systematic Review
- Liposomal Bupivacaine, Plain Bupivacaine, and Saline for Transversus Abdominis Plane Blocks: The CLEVELAND Randomized Trial.
Turan A, Ali Sakr Esa W, Brooker J, et al. · Anesthesiology 2026 · Randomized Controlled Trial
- Systematic Review of Liposomal Bupivacaine (Exparel) for Postoperative Analgesia.
Vyas KS, Rajendran S, Morrison SD, et al. · Plast Reconstr Surg 2016 · Systematic Review
- Addition of Liposomal Bupivacaine to Standard Bupivacaine versus Standard Bupivacaine Alone in the Supraclavicular Brachial Plexus Block: A Randomized Controlled Trial.
Chan TCW, Wong JSH, Wang F, et al. · Anesthesiology 2024 · Randomized Controlled Trial, Comparative Study
- Combined pectoralis and serratus anterior plane blocks with or without liposomal bupivacaine for minimally invasive thoracic surgery: A randomized clinical trial.
Marciniak D, Raymond D, Alfirevic A, et al. · J Clin Anesth 2024 · Randomized Controlled Trial
- Intrathecal anesthesia: ropivacaine versus bupivacaine.
Malinovsky JM, Charles F, Kick O, et al. · Anesth Analg 2000 · Clinical Trial, Comparative Study
Sponsor: Pacira Pharms INC
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.